Phenothiazines: Potential management of Creutzfeldt-Jacob disease and its variants

International Journal of Antimicrobial Agents

Volumn 18, Issue 5, 2001, Pages 411-417

  Amaral, Leonard ^a   Kristiansen, Jette Elisabeth ^b  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b Klinisk Mikrobiologisk Afdeling   (Denmark)

Author keywords

CJD; Intracellular activity; Phenothiazines

Indexed keywords

ANTIMALARIAL AGENT; CHLORPROMAZINE; MEPACRINE; METHYLENE BLUE; PHENOTHIAZINE; PRION PROTEIN; THIORIDAZINE; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; CALCIUM BINDING; CREUTZFELDT JAKOB DISEASE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; HUMAN; NEUROBLASTOMA CELL; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; REMISSION; REVIEW; VIRUS INACTIVATION;

CREUTZFELDT-JAKOB SYNDROME; HUMANS; PHENOTHIAZINES; PRIONS; TUMOR CELLS, CULTURED;

EID: 0035172946     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00432-0     Document Type: Review

References (97)

1. Prion-induced neuronal damage-the mechanisms of neuronal destruction in the subacute spongiform encephalopathies
2. Prion diseases of humans and animals: Their causes and molecular basis
3. The impact of Creutzfeldt-Jacob disease and variant Creutzfeldt-Jacob disease on plasma safety
4. Role of microglia in neuronal cell death in prion disease
5. Microglia and prion disease: A review
6. Prion protein and developments in its detection
7. Nobel pioneer gave CJD new lease of life
8. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
9. Antibodies inhibit prion propagation and clear cell cultures of prion-infectivity
10. The potential management of resistant infections with non-antibiotics
11. Phenothiazines: An alternative to conventional therapy for the initial management of multidrug resistant tuberculosis. A call for studies
12. Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: A review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy
13. Antimicrobial activity of phenothiaiznes: Potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries
14. Chemotherapeutics: Scientific principles, methods, and results
15. Dell'azione sedativa del bleu di metilene in vaire forme di psicosi
16. Recherches sur les dimethylaminopropyl N-phenothiazines
17. Studies of phenothiazine, antiseptic value of phenothiazines in urinary tract infections
18. Research on phenothiazine as an antihelmintic
19. L'antihistaminique 3277 RP (Phenergan) agit-il curativement dans la tuberculose experimentale de la souris?
20. Contribution à l'étude des propriétés antibiotiques de la chlorpromazine ou 4560 RP
21. Studies on the antitubercular action of some phenothiazine derivatives in vitro
22. The antibacterial effect of selected phenothiazines and thioxanthenes on slow growing mycobacteria
23. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis
24. Comparative in vitro activity of phenothiazines against multi-drug resistant Mycobacterium tuberculosis
25. Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines
26. Antibacterial effects of four phenothiazines
27. Dyes, antipsychotic drugs and antimicrobial activity
28. Effects of chlorpromazine on the cell envelope proteins of Echerichia coli
29. Effects of some tricyclic psychopharmacons and structurally related compounds on motility of Proteus vulgaris
30. Synergistic effect of chlorpromazine on the activity of some antibiotics
31. Synergistic effect of promethazine with gentamicin recurring pyelonephritis
32. Role of chlorpromazine in the treatment of pulmonary tuberculosis in psychiatric patients
33. Antimycobacterial activity of methdilazine (Md): An antimicrobic phenothiazine
34. Trimipramine and other antipsychotics inhibit Campylobacter pylori in vitro
35. Testing negative for Helicobacter pylori after methylene blue spraying of gastric mucosa
36. Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pylori
37. The reversal of antibiotic resistance by phenothiazines
38. Virus inactivation of fresh plasma
39. Inactivation of viruses in human plasma
40. Influence of chlorpromazine on the replication of influenza virus in chickembryo cells
41. Inhibition of SV40 DNA replication in vitro by chlorpromazine
42. Inhibition of arenavirus multiplication in vitro by phenotiazines
43. Virology. Inhibition of measles virus budding by phenothiazines
44. Verapamil and chlorpromazine inhibit the budding of Sindbis and vesicularstomatitis viruses from infected chicken embryo fibroblasts
45. Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists
46. Examination of potential inhibitors of hepatitis A virus uncoating
47. Trifluoperazine and its metal complexes inhibit the Moloney leukemia virusreverse transcriptase
48. Inhibition of HIV infection of H9 cells by chlorpromazine derivatives
49. Redristribution of basic drugs into cardiac blood from surrounding tissues during early stages postmortem
50. Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine
51. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats
52. Chlorpromazine: A drug potentially useful for treating mycobacterial infections
53. Intracellular activity of clinical concentrations of thioridazine against phagocytosed Staphylococcus aureus: Evidence in support of its use for the management of recurrent S. aureus infections
54. Activity of oral drugs against Leishmania tropica in human macrophages in vitro
55. Antileishmanial activity of chlorpromazine
56. Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants
57. The role of lysosomes in the cellular distribution of thioridazine and potentialdrug interactions
58. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes
59. Phenothiazines and calmodulin
60. Modifiers of calcium action
61. Inhibitor of calmodulin and calmodulin dependent enzymes
62. Structure-antitubercular activity relationship of phenothiazine-type calmodulin antagonists
63. The effect of chlorpromazine on the outer cell wall constituents of Salmonella typhimurium ensuring resistance to the drug
64. Effect of chlorpromazine on the ultrastructure of Staphylococcus aureus
65. Sublethal concentrations of antibiotics, effects on bacteria and the immune system
66. Penicillin binding protein site on the Escherichia coli cell envelope
67. Penicillin binding proteins of filaments of E. coli induced by low concentrations of nalidixic acid, oxolinic acid, novobiocin or nitrofurantoin
68. Preventing drug access to targets: Cell surface permeability barriers and active efflux in bacteria
69. Cancer research : Drug resistance, new targets and drugs in development
70. Monitoring interactions at ATP-dependent drug efflux pumps
71. Rapid detection of efflux pumps and their relation with drug resistance in yeastcells
72. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells
73. Drugs and DNA: Uncoiling of the DNA double helix as evidence of intercalation
74. ESR spectroscopy of flow-oriented cation radicals of phenothiazine derivativesand phenoxathiin intercalated in DNA
75. Regulation of erythrocyte ghost membrane mechanical stability by chlorpromazine
76. Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia
77. Regulation of endocytic traffic by rho family GTPases
78. 2+/calmodulin kinase II inhibitor KN-62
79. Inhibition of nicotinic acetylcholine receptors and calcium channels byclozapine in bovine adrenal chromaffin cells
80. Rapid endocytosis of interleukin 2 receptors when clathrin-coated pitendocytosis is inhibited
81. Inhibition by trifluoperazine and digitonin of several forms of pinocytosis
82. Membrane environment alters the conformational structure of the recombinant human prion protein
83. Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis
84. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations
85. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation
86. Modifications of oligodendroglial cells in spongiform encephalopathies
87. A protease-resistant protein is a structural component of the scrapie prion
88. Cleavage of the amino terminus of the prion protein by reactive oxygen species
89. Methylene blue derivatives-suitable photoantimicrobials for blood product disinfection?
90. Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp
91. Phenothiazine photosensitizers. III. Activity of methylene blue derivatives against pigmented melanoma cell lines
92. Drug-induced hepatotoxicity
93. A review of epidemiological research on drug induced acute liver injury using general practice research data base in the United Kingdom
94. Ocular side effects of selected systemic drugs
95. Drug-induced agranulocytosis
96. Photo-induced free radicals from chlorpromazine and related phenothiazines: Relationship to phenothiazine induced photosensitization
97. The antimicrobial activity of psychotherapeutic drugs and their stereo-isomeric analogues